Acquisition legacy Cayenne Medical was acquired by Zimmer Biomet in 2016, indicating access to a larger distributor network, established sales channels, and potential preferential treatment in Zimmer Biomet-supported facilities. Leverage this relationship to position Cayenne products within Zimmer Biomet customer bases and bundled offerings.

Knee and shoulder focus Product lines target soft tissue reconstruction for knee and shoulder, including multi-ligament fixation, meniscal repair, bone-tendon bone fixation, and shoulder rotator cuff/labral repair. Identify opportunities with orthopedic centers performing arthroscopic procedures and seek turnkey solutions that reduce procedure steps and costs.

Partial knee niche Recent Mirror Partial Knee System expansion introduces ligament-sparing technology across range of motion. This niche can be marketed to surgeons seeking tissue-preserving options and could align with centers focusing on joint-sparing approaches and quicker patient recovery.

Growing but small scale Revenue range is modest ($1M–$10M) with a mid-sized funding cushion ($57M). There is appetite for expansion but limited internal bench strength; strategic partnerships, co-marketing with Zimmer Biomet, and targeted surgeon education could unlock higher adoption rates without heavy capital outlay.

Clinical and cost benefits Mission emphasizes patient outcomes and reducing cost of care. Position offerings as procedural simplification, time savings, and potentially lower complication or revision rates to drive adoption in cost-conscious payers and high-volume centers.